CONTEXT: Intraocular melanoma of the ciliary body and choroid is the most common primary ocular malignant tumor in adults and the most common noncutaneous melanoma. OBJECTIVE: To describe the most salient clinical features, histopathologic findings, and treatment modalities of intraocular melanoma, as well as the novel therapies currently being tested. DATA SOURCES: Clinically, it is important to determine which lesions carry a worse prognosis so as to offer patients the best treatment modalities available. Tumor location, size, histopathology, cytogenetic abnormalities, and tumor profiling are all used in determining the risk of death from metastatic disease of uveal melanocytic lesions. Despite successful local tumor control, up to 50% of patients have metastatic disease within 15 years of diagnosis; there is no effective treatment for metastatic disease. CONCLUSIONS: Pathologists should be aware of the importance of tumor gross description, cellular histopathology classification, the use of fine-needle aspiration biopsy coupled with cytogenetics, and the new classification of uveal malignant melanomas that is based on chromosome 3 status.
CONTEXT: Intraocular melanoma of the ciliary body and choroid is the most common primary ocular malignant tumor in adults and the most common noncutaneous melanoma. OBJECTIVE: To describe the most salient clinical features, histopathologic findings, and treatment modalities of intraocular melanoma, as well as the novel therapies currently being tested. DATA SOURCES: Clinically, it is important to determine which lesions carry a worse prognosis so as to offer patients the best treatment modalities available. Tumor location, size, histopathology, cytogenetic abnormalities, and tumor profiling are all used in determining the risk of death from metastatic disease of uveal melanocytic lesions. Despite successful local tumor control, up to 50% of patients have metastatic disease within 15 years of diagnosis; there is no effective treatment for metastatic disease. CONCLUSIONS: Pathologists should be aware of the importance of tumor gross description, cellular histopathology classification, the use of fine-needle aspiration biopsy coupled with cytogenetics, and the new classification of uveal malignant melanomas that is based on chromosome 3 status.
Authors: A S Pappo; G T Armstrong; W Liu; D K Srivastava; A McDonald; W M Leisenring; S Hammond; M Stovall; J P Neglia; L L Robison Journal: Pediatr Blood Cancer Date: 2012-08-08 Impact factor: 3.167
Authors: Rhonda C Kines; Isabella Varsavsky; Sanghamitra Choudhary; Debaditya Bhattacharya; Sean Spring; Roger McLaughlin; Shin J Kang; Hans E Grossniklaus; Demetrios Vavvas; Stephen Monks; John R MacDougall; Elisabet de Los Pinos; John T Schiller Journal: Mol Cancer Ther Date: 2017-12-14 Impact factor: 6.261
Authors: James Thomas Patrick Decourcy Hallinan; Premilla Pillay; Lilian Hui Li Koh; Kong Yong Goh; Wai-Yung Yu Journal: Korean J Radiol Date: 2016-08-23 Impact factor: 3.500
Authors: Yao Chen; Xiaoqin Lu; Diego E Montoya-Durango; Yu-Hua Liu; Kevin C Dean; Douglas S Darling; Henry J Kaplan; Douglas C Dean; Ling Gao; Yongqing Liu Journal: Sci Rep Date: 2017-03-03 Impact factor: 4.379
Authors: Lorenzo Rinaldo; Sarah Chao Ying Xu; Scott D Eggers; Diva R Salomão; John J Chen; Aditya Raghunathan Journal: Ocul Oncol Pathol Date: 2017-12-16